Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-17

Clinical Trial Update: Mortality Reduction After Oral Azithromycin: Morbidity Study [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating mortality reduction after oral azithromycin in childhood mortality.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Childhood Mortality | Phase 4 | Status: COMPLETED